Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus

Osteoprotegerin, Soluble Receptor Activator of Nuclear Factor-κB Ligand, and Subclinical Atherosclerosis in Children and Adolescents with Type 1 Diabetes Mellitus

Aims. To evaluate carotid intima-media thickness (cIMT) and biomarkers of the osteoprotegerin/receptor activator of nuclear factor-κB ligand (OPG/RANKL) system in type 1 diabetes (T1DM) children and adolescents and controls. Subjects and Methods. Fifty six T1DM patients (mean ± SD age: 12.0 ± 2.7 y...

Full description

Bibliographic Details
Main Authors: Lambrinoudaki, Irene, Tsouvalas, Emmanouil, Vakaki, Marina, Kaparos, George, Stamatelopoulos, Kimon, Augoulea, Areti, Pliatsika, Paraskevi, Alexandrou, Andreas, Creatsa, Maria, Karavanaki, Kyriaki
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833004/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833004/

Similar Items